PR001 (LY3884961)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PR001 (LY3884961), covering 2026-03-13 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) [Phase 1, Phase 2]